What are the potential interactions between Wellbutrin (bupropion) and Adderall (amphetamine and dextroamphetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Potential Interactions Between Wellbutrin (Bupropion) and Adderall (Amphetamine and Dextroamphetamine)

Concurrent use of bupropion (Wellbutrin) and amphetamine/dextroamphetamine (Adderall) should be approached with caution due to the increased risk of seizures, cardiovascular effects, and potential for serotonin syndrome. While this combination is sometimes prescribed for ADHD treatment, careful monitoring is essential to minimize risks.

Key Interaction Concerns

  • Seizure Risk: Bupropion is associated with a dose-dependent risk of seizures, which may be potentiated when combined with Adderall 1

  • Cardiovascular Effects: Both medications can increase blood pressure and heart rate, potentially causing additive cardiovascular effects 2

    • Increased monitoring of vital signs is necessary when these medications are used together
  • Serotonin Syndrome Risk: Although bupropion has milder effects on serotonergic activity compared to SSRIs, cases of serotonin syndrome have been reported with bupropion combinations 3

    • Symptoms include confusion, agitation, myoclonus, altered consciousness, and autonomic instability
  • Drug Metabolism Interactions: Bupropion inhibits the cytochrome P450 2D6 pathway, which could potentially increase blood levels of amphetamines 3

Clinical Considerations

  • Dosing Adjustments:

    • When used together, lower initial doses of both medications may be warranted 1
    • Bupropion SR typically starts at 100-150 mg daily, with maintenance dose of 100-150 mg twice daily 1
    • Careful titration is essential to minimize adverse effects
  • Monitoring Requirements:

    • Regular assessment of blood pressure and heart rate 2
    • Monitoring for neurological symptoms including tremors, seizures, or altered mental status 2, 3
    • Assessment for insomnia, which both medications can cause 1
  • Therapeutic Considerations:

    • Bupropion has been studied as an alternative to stimulants for ADHD treatment, showing efficacy comparable to methylphenidate in some studies 4, 5
    • Bupropion has a significantly lower rate of sexual adverse events compared to many antidepressants 1

Warning Signs Requiring Immediate Attention

  • Seizures: Discontinue both medications and seek emergency care 2

  • Severe Hypertension: Systolic BP >180 mmHg or diastolic BP >120 mmHg requires urgent evaluation 2

  • Serotonin Syndrome: Confusion, agitation, myoclonus, hyperthermia, and autonomic instability require immediate discontinuation and medical attention 3

  • Psychiatric Symptoms: Worsening anxiety, agitation, or emergence of suicidal ideation 1

Special Populations

  • Pregnancy: Limited data exists on the combination, though individual safety profiles have been studied 1

    • Bupropion has possible associations with cardiovascular malformations in some studies 1
    • Amphetamines have shown possible increased risks for NICU admission 1
  • Patients with Seizure Disorders: This combination should generally be avoided in patients with a history of seizures 1

  • Patients with Cardiovascular Disease: Use with extreme caution in patients with pre-existing hypertension, arrhythmias, or structural heart disease 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Research

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.